{"id": "1409015647007383561", "creation": 1624770483.0, "user_id": "1392599444936331264", "social_network": "twitter", "nsfw": false, "request": ["d47670bd-00d9-4b4b-b654-af12857ee504"], "metrics": {"d47670bd-00d9-4b4b-b654-af12857ee504": {"retweet_count": 4, "reply_count": 1, "like_count": 17, "quote_count": 0}}, "text": "I have no issue sitting back and letting @DrGChamberland de-risk #QIXLEEF with the on-going #FDA phase 2 trial against #morphine so #bigpharma can acquire for many multiples of current valuation.  $tbp $tbpmf @TetraBioPharma $jazz @bccozadd $jnj #cancer #pain #opioid #cannabis https://t.co/jKtrMkx5M7", "first_save": 1635509975.555947, "hashtags": ["#QIXLEEF", "#FDA", "#MORPHINE", "#BIGPHARMA", "#CANCER", "#PAIN", "#OPIOID", "#CANNABIS"]}